NEDO Challenge recognizes D-Wave Quantum technology in drug discovery breakthrough

NEDO Challenge recognizes D-Wave Quantum technology in drug discovery breakthrough
D-Wave Quantum powers NEDO win

D-Wave Quantum announced that its customer, Shionogi, secured first place in the Quality of Life category at the NEDO Challenge. The award-winning project utilized D-Wave Quantum’s technology for quantum-assisted drug discovery research.

The recognition highlights concrete achievements in research methods that benefit pharmaceutical innovation through the application of quantum computing solutions.

D-Wave Quantum recently reported that its stock slipped 1% to $11.54 ahead of its upcoming third quarter 2026 results release scheduled for November 10, according to company filings. Earlier, D-Wave Quantum entered a multi-year agreement with SkyWater Foundry to advance semiconductor manufacturing for quantum technology applications, as detailed in a prior collaboration announcement.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.